RXO (RXO) Stock Looks Cheap On Cash Flow While Sales Look Full

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

RXO stock has surged year to date, yet valuation checks are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable discount while market based multiples lean expensive.

RXO has returned 114.9% year to date, which puts extra focus on whether the current price still leaves room for long term upside. Recent enthusiasm around RXO's trading outlook and AI driven strategies can support growth expectations, but weaker sales volumes and a short cash runway may limit how much investors are willing to pay for that story. RXO scores 4 out of 6 on valuation checks, which is a mixed picture rather than a clear bargain or clear overvaluation. You can see the detail behind that score at 4 out of 6.

For investors, the debate is whether RXO's strong share price run has already captured the upside suggested by the Discounted Cash Flow (DCF) estimate or if the current market premium on multiples still leaves a margin of safety.

RXO delivered 65.1% returns over the last year. See how this stacks up to the rest of the Transportation industry.

Is RXO a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) method values RXO by projecting its future cash generation to shareholders and discounting it back to today. For RXO, the latest twelve month free cash flow is a loss of about $21.8 million, so the model assumes a recovery path rather than steady current profitability.

Based on those projections, the DCF model points to an estimated intrinsic value of about $49.47 per share, which implies RXO trades at a 44.2% discount to that estimate and screens as undervalued. RXO stock recently touching a 52 week high despite a reported adjusted loss and mixed analyst sentiment helps explain why the market price has moved up. At the same time, the DCF suggests the cash flow outlook supports a higher level than today's quote.

On this cash flow view, RXO stock currently looks undervalued relative to its Discounted Cash Flow (DCF) intrinsic value estimate.

Our Discounted Cash Flow (DCF) analysis suggests RXO is undervalued by 44.2%. Track this in your watchlist or portfolio, or discover 43 more high quality undervalued stocks.RXO Discounted Cash Flow as at Jul 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for RXO.

Does RXO Look Pricey on Sales?

For a business like RXO where earnings are currently weak, the P/S multiple can be a cleaner way to see what investors are paying for each dollar of revenue. RXO trades on a P/S of about 0.8x, which is below both the Transportation industry average of roughly 1.2x and a peer group average closer to 1.8x. On simple revenue terms, the stock does not screen as expensive.

Story Continues

However, the fair P/S ratio implied by the model is about 0.7x, a touch lower than RXO's current 0.8x. This suggests the shares are pricing in more than the model would support given its view of growth, profitability and risks. That gap is not huge, but it tilts the message from this framework toward RXO stock looking richer than the underlying fundamentals alone might justify.

On this P/S yardstick, RXO screens as slightly overvalued relative to the fair multiple implied by its fundamentals.NYSE:RXO P/S Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The RXO Narrative: What Would Justify Today's Price?

For RXO, Simply Wall St Narratives act as the link between the DCF and multiples debate and the underlying assumptions about growth, margins and earnings that would need to hold for the stock to be worth materially more or less than it is today. They sit on the company's Community page. Each narrative connects its number to a clear view on where RXO's growth, profitability and risks could go next, giving you something concrete to revisit as fresh information comes through.

One of the top community narratives on RXO: 28% overvalued

"Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high..."

Read one of the top narratives on RXO

Do you think there's more to the story for RXO? Head over to our Community to see what others are saying!

The Bottom Line

For RXO, the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount, while the market multiple view leans toward the stock looking overvalued on current assumptions. That split largely reflects a DCF that is more willing to look through near term pressures in cash generation, compared with a multiples framework that is more anchored to what peers and the market are currently paying for revenue and risk.

What matters from here is whether RXO can deliver the cash flow and margin progress implied by the intrinsic value estimate, without stretching its balance sheet, to a degree that convinces the market that today's multiple is not already doing most of the work.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include RXO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments